Figure 2
DC-SIGN binding to surface IgM+ primary FL cells. Representative FACS plots of 3 FL samples simultaneously stained within the same tube to detect sIgM expression and soluble DC-SIGN binding (n = 6). Analysis (FlowJo) of singlet live cells initially allowed examination of sIgM expression (A). Populations positive for sIgM were gated to determine DC-SIGN binding on these cells. (B) Representative FACS plot of a control experiment to show that recombinant DC-SIGN-Fc binding is not affected by AT10 (anti-CD32) antibody or by the FcR-blocking reagent. (C) Analysis of GeoMFI data (GraphPad Prism) found that expression of sIgM was significantly correlated to binding of DC-SIGN (Spearman rank test). This correlation was confirmed further within samples of FL cells showing double peaks of high and low sIgM expression.

DC-SIGN binding to surface IgM+ primary FL cells. Representative FACS plots of 3 FL samples simultaneously stained within the same tube to detect sIgM expression and soluble DC-SIGN binding (n = 6). Analysis (FlowJo) of singlet live cells initially allowed examination of sIgM expression (A). Populations positive for sIgM were gated to determine DC-SIGN binding on these cells. (B) Representative FACS plot of a control experiment to show that recombinant DC-SIGN-Fc binding is not affected by AT10 (anti-CD32) antibody or by the FcR-blocking reagent. (C) Analysis of GeoMFI data (GraphPad Prism) found that expression of sIgM was significantly correlated to binding of DC-SIGN (Spearman rank test). This correlation was confirmed further within samples of FL cells showing double peaks of high and low sIgM expression.

Close Modal

or Create an Account

Close Modal
Close Modal